The tof-guard neuromuscular transmission monitor and its use in horses

It has been emphasized in the human medical literature, that when using a neuromuscular blocking agent, it is of vital importance the monitoring of the neuromuscular block and that these agents should never be used without it. The purpose of this study was to evaluate the use of the neuromuscular transmission monitor TOF-Guard in horses. Twelve horses were randomly assigned whether to receive pancuronium or atracurium as the neuromuscular blocking agent. All horses were pre-medicated with romifidine, anaesthesia induced with diazepam and ketamine and maintenance with halothane. Abolition of spontaneous ventilation was accomplished by the administration of atracurium or pancuronium. The time from injection of the muscle relaxant agent to the onset of maximum block (T1=0), recovery of T1 to 25% and the recovery of TOF ratio to 0.7 were recorded, as was the time for recovery of T1 from 25 to 75%. It was concluded that it is very important the neuromuscular transmission monitoring during the use of a nondepolarizing neuromuscular blocking agent, since it provides a safer anaesthetic and surgical procedure with the use of adequate dosages and due to the impossibility of a superficialization of the neuromuscular blockade during a surgical procedure. The TOF-Guard showed to be a good option for neuromuscular monitoring in horses.

[1]  G. Meakin,et al.  A comparison of acceleromyography and mechanomyography for determination of the dose–response curve of rocuronium in children , 1997, Anaesthesia.

[2]  S. Piepenbrock,et al.  Intubationsbedingungen und Verlauf der neuromuskulären Blockade nach Rocuronium bei endoskopischen Operationen in der HNO-Heilkunde , 1997, Der Anaesthesist.

[3]  M. Lamy,et al.  Elevated Plasma Alpha1-Acid Glycoprotein Levels: Lack of Connection to Resistance to Vecuronium Blockade Induced by Anticonvulsant Therapy , 1997, Journal of Neurosurgical Anesthesiology.

[4]  M. Lamy,et al.  ELEVATED PLASMA ALPHA1-ACID GLYCOPROTEIN (AAG) DOES NOT EXPLAIN THE RESISTANCE TO VECURONIUM BLOCKADE INDUCED BY ANTICONVULSANTS , 1997 .

[5]  S. Piepenbrock,et al.  [Intubation conditions and the development of neuromuscular blockade with rocuronium in endoscopic ORL surgery]. , 1997, Der Anaesthesist.

[6]  U. Hodges.  Vecuronium infusion requirements in paediatric patients in intensive care units: the use of acceleromyography. , 1997, British journal of anaesthesia.

[7]  J. Lo,et al.  Recovery from Mivacurium Block with or without Anticholinesterase following Continuous Infusion in Obstetric Patients , 1996, Anaesthesia and intensive care.

[8]  J. Ansermino,et al.  Acceleromyography improves detection of residual neuromuscular blockade in children , 1996, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[9]  J. Thurmon,et al.  Lumb & Jones Veterinary Anesthesia , 1996 .

[10]  M. Lamy,et al.  Comparison of neuromuscular block of atracurium and rocuronium in adults. , 1996, Acta anaesthesiologica Belgica.

[11]  C. Melloni.  [A new instrument for neuromuscular transmission monitoring: the accelerometer Tofguard. Comparative study of isometric force transduction in the assessment of pipecuronium dose-response relationship]. , 1995, Minerva Anestesiologica.

[12]  R. Mirakhur,et al.  The TOF‐Guard neuromuscular transmission monitor , 1995, Anaesthesia.

[13]  T. Hiraki,et al.  [A new neuromuscular transmission monitor (TOF Guard): the rationale behind the method and its clinical usefulness]. , 1994, Masui. The Japanese journal of anesthesiology.

[14]  W. Muir,et al.  Equine Anesthesia: Monitoring and Emergency Therapy , 1991 .

[15]  T. Pedersen,et al.  Does perioperative tactile evaluation of the train-of-four response influence the frequency of postoperative residual neuromuscular blockade? , 1990, Anesthesiology.

[16]  T. Hill,et al.  The effect of the organophosphate trichlorfon on the neuromuscular blocking activity of atracurium in halothane-anesthetized horses. , 1989, Journal of veterinary pharmacology and therapeutics.

[17]  D. Arpin,et al.  Neuromuscular and cardiovascular effects of atracurium administered to healthy horses anesthetized with halothane. , 1988, American journal of veterinary research.

[18]  E. Steffey,et al.  Cardiovascular and neuromuscular effects of pancuronium bromide in the pony. , 1983, American journal of veterinary research.

[19]  J. Hopkins,et al.  Mechanical responses to peroneal nerve stimulation in halothane-anesthetized horses in the absence of neuromuscular blockade and during partial nondepolarizing blockade. , 1983, American journal of veterinary research.

[20]  R. Jones,et al.  A technique for the investigation of the action of drugs on the neuromuscular junction in the intact horse. , 1976, The British veterinary journal.

[21]  Bowen Jm.  Monitoring neuromuscular function in intact animals. , 1969 .

[22]  J. Bowen.  Monitoring neuromuscular function in intact animals. , 1969, American Journal of Veterinary Research.